What’s more, as shown in Supplementary Figure S16E, STAT5A expression was characterized to be positively linked with CTL infiltration levels in endometrial carcinoma (r = 0.298, p = 1.55e−12), acute myeloid leukemia (r = 0.220, p = 7.84e−5), neuroblastoma (r = 0.578, p = 4.53e−36), and triple negative breast cancer (r = 0.467, p = 5.25e−14). Here, STAT5A is linked to neuroblastoma.